{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:48:16Z","timestamp":1792601296754,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["T2495260"],"award-info":[{"award-number":["T2495260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Clinical Research Center for Cell Therapy","award":["23J41900100"],"award-info":[{"award-number":["23J41900100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01222-5","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:04:41Z","timestamp":1778951081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CTMP-REV7 axis modulates MHC-I antigen presentation via CDK1-AKT crosstalk in MSI-L\/MSS colorectal cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Cheng","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhui","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"1222_CR1","doi-asserted-by":"publisher","unstructured":"T. Andr\u00e9, L.A. Jr Diaz et al., EYNOTE-177 Investigators. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N. Engl. J. Med. 383(23), 2207\u20132218 (2020). https:\/\/doi.org\/10.1056\/NEJMoa2017699. PMID: 33264544","DOI":"10.1056\/NEJMoa2017699"},{"key":"1222_CR2","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407), 330-7 (2012). https:\/\/doi.org\/10.1038\/nature11252. PMID: 22810696","DOI":"10.1038\/nature11252"},{"issue":"11","key":"1222_CR3","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","volume":"16","author":"AM Goodman","year":"2017","unstructured":"A.M. Goodman, R. Kurzrock, al.Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers. Mol. Cancer Ther. 16(11), 2598\u20132608 (2017). https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0386. Epub 2017 Aug 23. PMID: 28835386","journal-title":"Mol. Cancer Ther."},{"key":"1222_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.celrep.2016.03.075","volume":"15","author":"M Giannakis","year":"2016","unstructured":"M. Giannakis, M. Yamauchi et al., Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell. Rep. 15, 857\u2013865 (2016). https:\/\/doi.org\/10.1016\/j.celrep.2016.03.075","journal-title":"Cell. Rep."},{"issue":"18","key":"1222_CR5","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1200\/JCO.19.03296","volume":"38","author":"S Fukuoka","year":"2020","unstructured":"S. Fukuoka, K. Shitara et al., Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603). J. Clin. Oncol. 38(18), 2053\u20132061 (2020). Epub 2020 Apr 28. PMID: 32343640","journal-title":"J. Clin. Oncol."},{"issue":"10395","key":"1222_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0140-6736(23)00772-9","volume":"402","author":"A Dasari","year":"2023","unstructured":"A. Dasari, S. Lonardi et al., FRESCO-2 Study Investigators. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. Lancet. 402(10395), 41\u201353 (2023). https:\/\/doi.org\/10.1016\/S0140-6736(23)00772-9. Epub 2023 Jun 15. PMID: 37331369","journal-title":"Lancet"},{"issue":"49","key":"1222_CR7","doi-asserted-by":"publisher","first-page":"e2208900119","DOI":"10.1073\/pnas.2208900119","volume":"119","author":"LE Stopfer","year":"2022","unstructured":"L.E. Stopfer, F.M. White et al., MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas. Proc. Natl. Acad. Sci. U S A 119(49), e2208900119 (2022). https:\/\/doi.org\/10.1073\/pnas.2208900119. Epub 2022 Dec 1. PMID: 36454758; PMCID: PMC9894220","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"1222_CR8","doi-asserted-by":"crossref","unstructured":"G. Zhou, M.J. Bruno et al., Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer. Oncoimmunology 7(7), e1448332 (2018). https:\/\/pubmed.ncbi.nlm.nih.gov\/29900067\/. PMID: 29900067","DOI":"10.1080\/2162402X.2018.1448332"},{"issue":"10","key":"1222_CR9","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00262-022-03182-9","volume":"71","author":"M Thibaudin","year":"2022","unstructured":"M. Thibaudin, F. Ghiringhelli, Targeting et al., PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer. Cancer Immunol. Immunother. 71(10), 2549\u20132563 (2022). https:\/\/doi.org\/10.1007\/s00262-022-03182-9. Epub 2022 Mar 16. PMID: 35292828","journal-title":"Cancer Immunol. Immunother"},{"key":"1222_CR10","doi-asserted-by":"crossref","unstructured":"E. Lou, M.S. Choudhry, B.S. Moriarity et al., Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial. Lancet Oncol. 26(5), 559\u2013570 (2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/40315882\/. Epub 2025 Apr 29. PMID: 40315882","DOI":"10.1016\/S1470-2045(25)00083-X"},{"key":"1222_CR11","doi-asserted-by":"publisher","unstructured":"W. Liu, S. Dong, F. Hao, Y. Gao, Q. Wei, Lipid metabolic reprogramming in colorectal cancer: mechanisms and therapeutic strategies. Front. Immunol. 16, 1603032 (2025). https:\/\/doi.org\/10.3389\/fimmu.2025.1603032. PMID: 40718481; PMCID: PMC12289696","DOI":"10.3389\/fimmu.2025.1603032"},{"issue":"1","key":"1222_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"M.T. Snaebjornsson, S. Janaki-Raman, A. Schulze, Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell. Metab. 31(1), 62\u201376 (2020). Epub 2019 Dec 5. PMID: 31813823","journal-title":"Cell. Metab."},{"key":"1222_CR13","doi-asserted-by":"publisher","unstructured":"Y.N. Wang, Z.L. Zeng, J. Lu et al., CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis. Oncogene 37 (2018). https:\/\/doi.org\/10.1038\/s41388-018-0384-z","DOI":"10.1038\/s41388-018-0384-z"},{"key":"1222_CR14","doi-asserted-by":"publisher","unstructured":"X. Xiong, Y.A. Wen, R. Fairchild et al., Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer. Cell Death Dis. 11 (2020). https:\/\/doi.org\/10.1038\/s41419-020-02936-6","DOI":"10.1038\/s41419-020-02936-6"},{"key":"1222_CR15","doi-asserted-by":"publisher","unstructured":"L. Ma, C. Chen, C. Zhao et al., Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer. Signal Transduct Tar. 9 (2024). https:\/\/doi.org\/10.1038\/s41392-024-01772-w","DOI":"10.1038\/s41392-024-01772-w"},{"issue":"39","key":"1222_CR16","doi-asserted-by":"publisher","first-page":"e2302878120","DOI":"10.1073\/pnas.2302878120","volume":"120","author":"Z Liu","year":"2023","unstructured":"Z. Liu, W. Liu, W. Wang et al., CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing. P NATL. ACAD. SCI. USA 120(39), e2302878120 (2023). https:\/\/doi.org\/10.1073\/pnas.2302878120","journal-title":"P NATL. ACAD. SCI. USA"},{"key":"1222_CR17","doi-asserted-by":"publisher","unstructured":"C. Brocker, C. Carpenter, D.W. Nebert, V. Vasiliou, Evolutionary divergence and functions of the human acyl-CoA thioesterase gene (ACOT) family. Hum Genomics. 4(6), 411\u2009\u2013\u200920 (2010). https:\/\/doi.org\/10.1186\/1479-7364-4-6-411. PMID: 20846931","DOI":"10.1186\/1479-7364-4-6-411"},{"key":"1222_CR18","doi-asserted-by":"publisher","unstructured":"C. Moffat, E.L. Seifert et al., Acyl-CoA thioesterase-2 facilitates mitochondrial fatty acid oxidation in the liver. J Lipid Res. 55(12), 2458-70 (2014). https:\/\/doi.org\/10.1194\/jlr.M046961. Epub 2014 Aug 11. PMID: 25114170","DOI":"10.1194\/jlr.M046961"},{"issue":"5","key":"1222_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00018-013-1422-1","volume":"71","author":"V Tillander","year":"2014","unstructured":"V. Tillander, S.E. Alexson et al., Acyl-CoA thioesterase 9 (ACOT9) in mouse may provide a novel link between fatty acid and amino acid metabolism in mitochondria. Cell. Mol. Life Sci. 71(5), 933\u2013948 (2014). https:\/\/doi.org\/10.1007\/s00018-013-1422-1. Epub 2013 Jul 18. PMID: 23864032","journal-title":"Cell. Mol. Life Sci."},{"key":"1222_CR20","doi-asserted-by":"publisher","unstructured":"C. Liang, X. Wang, Z. Zhang et al., ACOT11 promotes cell proliferation, migration and invasion in lung adenocarcinoma. Transl. Lung Cancer R. 9 (2020). https:\/\/doi.org\/10.21037\/tlcr-19-509","DOI":"10.21037\/tlcr-19-509"},{"key":"1222_CR21","doi-asserted-by":"publisher","unstructured":"C. Ni, K. Zheng, Y. Gao et al., ACOT4 accumulation via AKT-mediated phosphorylation promotes pancreatic tumorigenesis. Cancer Lett. 498 (2021). https:\/\/doi.org\/10.1016\/j.canlet.2020.09.022","DOI":"10.1016\/j.canlet.2020.09.022"},{"key":"1222_CR22","doi-asserted-by":"publisher","unstructured":"S.H. Jung, H.C. Lee, H.J. Hwang et al., Acyl-CoA thioesterase 7 is involved in cell cycle progression via regulation of PKC\u03b6-p53-p21 signaling pathway. Cell Death Dis. 8 (2017). https:\/\/doi.org\/10.1038\/cddis.2017.202","DOI":"10.1038\/cddis.2017.202"},{"issue":"4","key":"1222_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.plipres.2010.04.001","volume":"49","author":"B Kirkby","year":"2010","unstructured":"B. Kirkby, J.K. Forwood et al., Functional and structural properties of mammalian acyl-coenzyme A thioesterases. Prog Lipid Res. 49(4), 366\u2013377 (2010). https:\/\/doi.org\/10.1016\/j.plipres.2010.04.001. Epub 2010 May 12. PMID: 20470824","journal-title":"Prog Lipid Res."},{"issue":"44","key":"1222_CR24","doi-asserted-by":"publisher","first-page":"43709","DOI":"10.1074\/jbc.M308198200","volume":"278","author":"JB Thoden","year":"2003","unstructured":"J.B. Thoden, H.M. Holden et al., The structure of 4-hydroxybenzoyl-CoA thioesterase from arthrobacter sp. strain SU. J. Biol. Chem. 278(44), 43709\u201343716 (2003). https:\/\/doi.org\/10.1074\/jbc.M308198200. Epub 2003 Aug 7. PMID: 12907670","journal-title":"J. Biol. Chem."},{"key":"1222_CR25","doi-asserted-by":"publisher","unstructured":"H. Zhao, B.M. Martin, M. Bisoffi, D. Dunaway-Mariano, The Akt C-terminal modulator protein is an acyl-CoA thioesterase of the Hotdog-Fold family. Biochemistry 48(24), 5507-9 (2009). https:\/\/doi.org\/10.1021\/bi900710w. PMID: 19453107","DOI":"10.1021\/bi900710w"},{"key":"1222_CR26","doi-asserted-by":"publisher","unstructured":"S.M. Maira, B.A. Hemmings et al., Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB\/Akt and v-Akt at the plasma membrane. Science 294(5541), 374\u2009\u2013\u200980 (2001). https:\/\/doi.org\/10.1126\/science.1062030. PMID: 11598301","DOI":"10.1126\/science.1062030"},{"key":"1222_CR27","doi-asserted-by":"publisher","unstructured":"A. Parcellier, L.A. Tintignac, E. Zhuravleva et al., Carboxy-Terminal Modulator Protein (CTMP) is a mitochondrial protein that sensitizes cells to apoptosis. Cell Signal 21 (2009). https:\/\/doi.org\/10.1016\/j.cellsig.2009.01.016","DOI":"10.1016\/j.cellsig.2009.01.016"},{"key":"1222_CR28","doi-asserted-by":"publisher","unstructured":"S. Chandrasekaran, M. Sasaki, C.D. Scharer et al., Phosphoinositide 3-Kinase signaling can modulate MHC class I and II expression. Mol. Cancer Res. 17 (2019). https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0545","DOI":"10.1158\/1541-7786.MCR-19-0545"},{"key":"1222_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI123540","author":"N Sivaram","year":"2019","unstructured":"N. Sivaram, P.A. McLaughlin, H.V. Han et al., Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. J. CLIN. INVEST. (2019). 129 J CLIN INVEST. https:\/\/doi.org\/10.1172\/JCI123540","journal-title":"J. CLIN. INVEST."},{"key":"1222_CR30","doi-asserted-by":"publisher","unstructured":"H. Ono, T. Asano et al., Carboxy-terminal modulator protein induces Akt phosphorylation and activation, thereby enhancing antiapoptotic, glycogen synthetic, and glucose uptake pathways. Am. J. Physiol. Cell Physiol. 293(5), C1576-85 (2007). https:\/\/doi.org\/10.1152\/ajpcell.00570.2006. Epub 2007 Jul 5. PMID: 17615157","DOI":"10.1152\/ajpcell.00570.2006"},{"issue":"20","key":"1222_CR31","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1158\/0008-5472.CAN-13-0518","volume":"73","author":"YP Liu","year":"2013","unstructured":"Y.P. Liu, P.J. Lu et al., Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer. Cancer Res. 73(20), 6194\u20136205 (2013). https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0518. Epub 2013 Aug 13. PMID: 23943800","journal-title":"Cancer Res."},{"key":"1222_CR32","doi-asserted-by":"publisher","unstructured":"J.W. Chang, S.N. Jung, J.H. Kim et al., Carboxyl-terminal modulator protein positively acts as an oncogenic driver in head and neck squamous cell carcinoma via regulating Akt phosphorylation. Sci. Rep. 6 (2016). https:\/\/doi.org\/10.1038\/srep28503","DOI":"10.1038\/srep28503"},{"issue":"26","key":"1222_CR33","doi-asserted-by":"publisher","first-page":"10740","DOI":"10.1073\/pnas.0904412106","volume":"106","author":"Q Zhou","year":"2009","unstructured":"Q. Zhou, S.E. Leeman, S. Amar, Signaling mechanisms involved in altered function of macrophages from diet-induced obese mice affect immune responses. P NATL. ACAD. SCI. USA 106(26), 10740\u201310745 (2009). https:\/\/doi.org\/10.1073\/pnas.0904412106","journal-title":"P NATL. ACAD. SCI. USA"},{"key":"1222_CR34","doi-asserted-by":"publisher","unstructured":"Q. Zhou, S.E. Leeman, S. Amar, Signaling mechanisms in the restoration of impaired immune function due to diet-induced obesity. P. Natl. Acad. Sci. USA. 108 (2011). https:\/\/doi.org\/10.1073\/pnas.1019270108","DOI":"10.1073\/pnas.1019270108"},{"issue":"1","key":"1222_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1083\/jcb.201302060","volume":"203","author":"T Listovsky","year":"2013","unstructured":"T. Listovsky, J.E. Sale, Sequestration of CDH1 by MAD2L2 prevents premature APC\/C activation prior to anaphase onset. J. Cell. Biol. 203(1), 87\u2013100 (2013). https:\/\/doi.org\/10.1083\/jcb.201302060","journal-title":"J. Cell. Biol."},{"issue":"1","key":"1222_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/j.gastro.2006.09.018","volume":"132","author":"A Goel","year":"2007","unstructured":"A. Goel, C.R. Boland et al., The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology. 132(1), 127\u2013138 (2007). https:\/\/doi.org\/10.1053\/j.gastro.2006.09.018. Epub 2006 Sep 20. PMID: 17087942","journal-title":"Gastroenterology"},{"key":"1222_CR37","doi-asserted-by":"publisher","unstructured":"B. Yuan, E. Gabrielson et al., Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin. Cancer Res. 12(2), 405\u2009\u2013\u200910 (2006). https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0903. PMID: 16428479","DOI":"10.1158\/1078-0432.CCR-05-0903"},{"key":"1222_CR38","doi-asserted-by":"publisher","unstructured":"C. Rimkus, K.P. Janssen, Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer. Int. J. Cancer 120(1), 207\u2009\u2013\u200911 (2007). https:\/\/doi.org\/10.1002\/ijc.22155. PMID: 17044027","DOI":"10.1002\/ijc.22155"},{"issue":"2","key":"1222_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.canlet.2007.03.021","volume":"254","author":"M Scintu","year":"2007","unstructured":"M. Scintu, P. Parrella, Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma. Cancer Lett. 254(2), 298\u2013307 (2007). https:\/\/doi.org\/10.1016\/j.canlet.2007.03.021. Epub 2007 May 10. PMID: 17498870","journal-title":"Cancer Lett."},{"issue":"9","key":"1222_CR40","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1091\/mbc.e02-04-0203","volume":"13","author":"CD Warren","year":"2002","unstructured":"C.D. Warren, F.A. Spencer, Distinct chromosome segregation roles for spindle checkpoint proteins. Mol. Biol. Cell. 13(9), 3029\u20133041 (2002). https:\/\/doi.org\/10.1091\/mbc.e02-04-0203. PMID: 12221113; PMCID: PMC124140","journal-title":"Mol. Biol. Cell."},{"issue":"26","key":"1222_CR41","doi-asserted-by":"publisher","first-page":"e2308690","DOI":"10.1002\/advs.202308690","volume":"11","author":"R Hosea","year":"2024","unstructured":"R. Hosea, V. Kasim et al., YY2\/BUB3 Axis promotes SAC Hyperactivation and Inhibits Colorectal Cancer Progression via Regulating Chromosomal Instability. Adv. Sci. (Weinh). 11(26), e2308690 (2024). https:\/\/doi.org\/10.1002\/advs.202308690. Epub 2024 Apr 29. PMID: 38682484; PMCID: PMC11234461","journal-title":"Adv. Sci. (Weinh)"},{"issue":"11","key":"1222_CR42","doi-asserted-by":"publisher","first-page":"101282","DOI":"10.1016\/j.xcrm.2023.101282","volume":"4","author":"Y Li","year":"2023","unstructured":"Y. Li, N.R. Mahadevan, M.G. Oser, Aurora A kinase inhibition induces accumulation of SCLC tumor cells in mitosis with restored interferon signaling to increase response to PD-L1. Cell. Rep. Med. 4(11), 101282 (2023). https:\/\/doi.org\/10.1016\/j.xcrm.2023.101282. PMID: 37992688; PMCID: PMC10694667","journal-title":"Cell. Rep. Med."},{"issue":"10","key":"1222_CR43","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ccell.2022.08.015","volume":"40","author":"S Kitajima","year":"2022","unstructured":"S. Kitajima, D.A. Barbie et al., MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer. Cancer Cell. 40(10), 1128\u20131144e8 (2022). https:\/\/doi.org\/10.1016\/j.ccell.2022.08.015. Epub 2022 Sep 22. PMID: 36150391; PMCID: PMC9561026","journal-title":"Cancer Cell."},{"issue":"6","key":"1222_CR44","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cell.2018.08.027","volume":"174","author":"SF Bakhoum","year":"2018","unstructured":"S.F. Bakhoum, L.C. Cantley, The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment. Cell. 174(6), 1347\u20131360 (2018). https:\/\/doi.org\/10.1016\/j.cell.2018.08.027. PMID: 30193109; PMCID: PMC6136429","journal-title":"Cell"},{"issue":"8","key":"1222_CR45","doi-asserted-by":"publisher","first-page":"e1003712","DOI":"10.1371\/journal.pgen.1003712","volume":"9","author":"M Pirouz","year":"2013","unstructured":"M. Pirouz, S. Pilarski, M. Kessel, A critical function of Mad2l2 in primordial germ cell development of mice. PLoS Genet. 9(8), e1003712 (2013). https:\/\/doi.org\/10.1371\/journal.pgen.1003712","journal-title":"PLoS Genet."},{"key":"1222_CR46","doi-asserted-by":"publisher","unstructured":"Y. Yang, Q. Liu, X. Guo et al., Systematic pan-cancer analysis identifies CDK1 as an immunological and prognostic biomarker. J. Oncol. 2022, 8115474 (2022). https:\/\/doi.org\/10.1155\/2022\/8115474","DOI":"10.1155\/2022\/8115474"},{"key":"1222_CR47","doi-asserted-by":"publisher","unstructured":"L. Chen, X. Zhang et al., Natural killer cell activation signature identifies cyclin B1\/CDK1 as a druggable target to overcome natural killer cell dysfunction and tumor invasiveness in melanoma. Pharmaceuticals (Basel). 18(5), 666 (2025). https:\/\/doi.org\/10.3390\/ph18050666. PMID: 40430484","DOI":"10.3390\/ph18050666"},{"key":"1222_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100625","author":"B Gy\u0151rffy","year":"2024","unstructured":"B. Gy\u0151rffy, Integrated Analysis of Public Datasets for the Discovery and Validation of Survival-Associated Genes in Solid Tumors. Innov. (2024). https:\/\/doi.org\/10.1016\/j.xinn.2024.100625","journal-title":"Innov."},{"key":"1222_CR49","doi-asserted-by":"publisher","unstructured":"J. Jumper, D. Hassabis et al., Highly accuratee protein structure prediction with AlphaFold. Nature 596(7873), 583\u2013589 (2021). https:\/\/doi.org\/10.1038\/s41586-021-03819-2. Epub 2021 Jul 15. PMID: 34265844","DOI":"10.1038\/s41586-021-03819-2"},{"key":"1222_CR50","doi-asserted-by":"publisher","unstructured":"R. Evans, D. Hassabis et al., Protein complex prediction with AlphaFold-Multimer. bioRxiv. 2021.10.04.463034. https:\/\/doi.org\/10.1101\/2021.10.04.463034","DOI":"10.1101\/2021.10.04.463034"},{"issue":"1","key":"1222_CR51","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/s41467-023-36979-y","volume":"14","author":"SY Lim","year":"2023","unstructured":"S.Y. Lim, E. Shklovskaya, J.H. Lee, The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma. Nat. Commun. 14(1), 1516 (2023). https:\/\/doi.org\/10.1038\/s41467-023-36979-y","journal-title":"Nat. Commun."},{"issue":"1","key":"1222_CR52","doi-asserted-by":"publisher","first-page":"e005592","DOI":"10.1136\/jitc-2022-005592","volume":"11","author":"B Zhang","year":"2023","unstructured":"B. Zhang, J. Li, Q. Hua, Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation. J. ImmunoTher Cancer. 11(1), e005592 (2023)","journal-title":"J. ImmunoTher Cancer"},{"issue":"1","key":"1222_CR53","doi-asserted-by":"publisher","first-page":"e140837","DOI":"10.1172\/JCI140837","volume":"131","author":"Y Fang","year":"2021","unstructured":"Y. Fang, L. Wang, C. Wan, MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation. J. Clin. Invest. 131(1), e140837 (2021)","journal-title":"J. Clin. Invest."},{"issue":"5","key":"1222_CR54","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/PAS.0000000000001653","volume":"45","author":"AC Dusenbery","year":"2021","unstructured":"A.C. Dusenbery, J.L. Maniaci, Hillerson NDet al. MHC class I loss in triple-negative breast cancer: a potential barrier to PD-1\/PD-L1 checkpoint inhibitors. Am. J. Surg. Pathol. 45(5), 701\u2013707 (2021). https:\/\/doi.org\/10.1097\/PAS.0000000000001653","journal-title":"Am. J. Surg. Pathol."},{"issue":"1\u20132","key":"1222_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"M.S. Rooney, S.A. Shukla, C.J. Wu et al., Molecular and genetic properties of tumors associated with local immune cytolytic activity. CELL. 160(1\u20132), 48\u201361 (2015). https:\/\/doi.org\/10.1016\/j.cell.2014.12.033","journal-title":"CELL"},{"key":"1222_CR56","doi-asserted-by":"publisher","unstructured":"A.M. Goodman, A. Castro, R.M. Pyke et al., MHC-I genotype and tumor mutational burden predict response to immunotherapy. Genome Med. 12 (2020). https:\/\/doi.org\/10.1186\/s13073-020-00743-4","DOI":"10.1186\/s13073-020-00743-4"},{"issue":"46","key":"1222_CR57","doi-asserted-by":"publisher","first-page":"33376","DOI":"10.1074\/jbc.M113.481408","volume":"288","author":"HW Kang","year":"2013","unstructured":"H.W. Kang, D.E. Cohen et al., Thioesterase superfamily member 2\/Acyl-CoA thioesterase 13 (Them2\/Acot13) regulates adaptive thermogenesis in mice. J. Biol. Chem. 288(46), 33376\u201333386 (2013). https:\/\/doi.org\/10.1074\/jbc.M113.481408. Epub 2013 Sep 26. PMID: 24072708; PMCID: PMC3829184","journal-title":"J. Biol. Chem."},{"key":"1222_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41421-020-0162-2","volume":"6","author":"L Zhong","year":"2020","unstructured":"L. Zhong, M.M. Hu, L.J. Bian, Y. Liu, Q. Chen, H.B. Shu, Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis. Cell. Discov. 6, 26 (2020). https:\/\/doi.org\/10.1038\/s41421-020-0162-2. PMID: 32351706; PMCID: PMC7186227","journal-title":"Cell. Discov"},{"issue":"7155","key":"1222_CR59","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nature06046","volume":"448","author":"D Santamar\u00eda","year":"2007","unstructured":"D. Santamar\u00eda, C. Barri\u00e8re, A. Cerqueira et al., Cdk1 is sufficient to drive the mammalian cell cycle. NATURE. 448(7155), 811\u2013815 (2007). https:\/\/doi.org\/10.1038\/nature06046","journal-title":"NATURE"},{"issue":"6","key":"1222_CR60","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","volume":"167","author":"JL Benci","year":"2016","unstructured":"J.L. Benci, A.J. Minn, Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade. Cell. 167(6), 1540\u20131554e12 (2016). https:\/\/doi.org\/10.1016\/j.cell.2016.11.022. PMID: 27912061; PMCID: PMC5385895","journal-title":"Cell"},{"issue":"1","key":"1222_CR61","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12933-023-01961-x","volume":"22","author":"N Subramanian","year":"2023","unstructured":"N. Subramanian, P. Arner, J. Laurencikiene, Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4\u2009+\u2009T cells. Cardiovasc. Diabetol. 22(1), 229 (2023). https:\/\/doi.org\/10.1186\/s12933-023-01961-x. PMID: 37046242; PMCID: PMC10099890","journal-title":"Cardiovasc. Diabetol."},{"key":"1222_CR62","doi-asserted-by":"crossref","unstructured":"W. Doerrler, K.R. Feingold, C. Grunfeld, Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 6(5), 478\u2009\u2013\u200984 (1994). https:\/\/pubmed.ncbi.nlm.nih.gov\/7827285\/. PMID: 7827285","DOI":"10.1016\/1043-4666(94)90074-4"},{"key":"1222_CR63","doi-asserted-by":"publisher","unstructured":"M. Krapi\u0107, F.M. Wensveen et al., NK cell-derived IFN\u03b3 mobilizes free fatty acids from adipose tissue to promote early B cell activation during viral infection. Nat Metab. 7(5), 985\u20131003 (2025). https:\/\/doi.org\/10.1038\/s42255-025-01273-2. Epub 2025 Apr 11. PMID: 40217117","DOI":"10.1038\/s42255-025-01273-2"},{"issue":"9","key":"1222_CR64","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1158\/0008-5472.CAN-20-3580","volume":"81","author":"X Lu","year":"2021","unstructured":"X. Lu, Y. Wang et al., Integrated Screens Identify CDK1 as a Therapeutic Target in Advanced Gastrointestinal Stromal Tumors. Cancer Res. 81(9), 2481\u20132494 (2021). https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-3580. Epub 2021 Mar 16. PMID: 33727226","journal-title":"Cancer Res."},{"key":"1222_CR65","doi-asserted-by":"publisher","unstructured":"Y. Tang, K. Ding et al., Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer. Cancer Lett. 588, 216798 (2024). https:\/\/doi.org\/10.1016\/j.canlet.2024.216798. Epub 2024 Mar 11. PMID: 38467181","DOI":"10.1016\/j.canlet.2024.216798"},{"key":"1222_CR66","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/annonc\/mdv615","volume":"27","author":"J Chen","year":"2016","unstructured":"J. Chen, C.C. Jiang, L. Jin, X.D. Zhang, Regulation of PD-L1: A Novel Role of Pro-Survival Signalling in Cancer. Ann. Oncol. 27, 409\u2013416 (2016)","journal-title":"Ann. Oncol."},{"issue":"24","key":"1222_CR67","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1038\/onc.2013.265","volume":"33","author":"E Hirsch","year":"2013","unstructured":"E. Hirsch, I. Franco et al., PI3K in cancer-stroma interactions: bad in seed and ugly in soil. ONCOGENE. 33(24), 3083\u20133090 (2013). https:\/\/doi.org\/10.1038\/onc.2013.265","journal-title":"ONCOGENE"},{"issue":"8","key":"1222_CR68","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s43018-023-00594-z","volume":"4","author":"D Brina","year":"2023","unstructured":"D. Brina, M. Troiani et al., The Akt\/mTOR and MNK\/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. Nat. Cancer. 4(8), 1102\u20131121 (2023). https:\/\/doi.org\/10.1038\/s43018-023-00594-z","journal-title":"Nat. Cancer"},{"key":"1222_CR69","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.semcancer.2017.04.015","volume":"48","author":"JS O\u2019Donnell","year":"2018","unstructured":"J.S. O\u2019Donnell, M. Mandala, PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux. Semin Cancer Biol. 48, 91\u2013103 (2018). https:\/\/doi.org\/10.1016\/j.semcancer.2017.04.015. Epub 2017 May 2. PMID: 28467889","journal-title":"Semin Cancer Biol."},{"key":"1222_CR70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","volume":"33","author":"L Shi","year":"2015","unstructured":"L. Shi, B.P. Tu, Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr. Opin. Cell. Biol. 33, 125\u2013131 (2015). https:\/\/doi.org\/10.1016\/j.ceb.2015.02.003. Epub 2015 Feb 20. PMID: 25703630; PMCID: PMC4380630","journal-title":"Curr. Opin. Cell. Biol."},{"key":"1222_CR71","doi-asserted-by":"publisher","unstructured":"A. Garcia-Diaz, A. Ribas et al., Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep. 19(6), 1189\u20131201 (2017). https:\/\/doi.org\/10.1016\/j.celrep.2017.04.031. PMID: 28494868","DOI":"10.1016\/j.celrep.2017.04.031"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01222-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:21:21Z","timestamp":1779391281000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01222-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":71,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1222"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01222-5","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human studies involving CRC tissue samples were performed after obtaining written informed consent from each participant and with the approval of the Ethics Committee of Shanghai Tenth People\u2019s Hospital (Approval No. 25KN307). All animal experiments were approved by the same Ethics Committee (Approval No. SHDSYY-2023-1740) and carried out in compliance with Tongji University\u2019s guidelines for laboratory animal welfare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}